Cargando…

Human and chicken antibodies to CCR5-ECL1 block mucosal and systemic HIV infection

Detalles Bibliográficos
Autores principales:	Lopalco, Lucia, Pastori, Claudia, Bomsel, Morgane, Clivio, Alberto, Alberti, Chiara, Diomede, Lorenzo, Longhi, Renato, Colombo, Giorgio, Consonni, Roberto, Lazzarin, Adriano
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1716921/ http://dx.doi.org/10.1186/1742-4690-3-S1-S14

Ejemplares similares

P11-13. Antigen presentation and immune priming of CCR5-ECL1 receptor in Peyer's patches B cells
por: Lopalco, L, et al.
Publicado: (2009)

P19-34. Formal breaking of B cell tolerance to induce HIV blocking CCR5 specific antibodies in mouse model
por: Lopalco, L, et al.
Publicado: (2009)

Editorial: Mucosal immunity to HIV and SARS-CoV-2 infection and vaccination
por: Bomsel, Morgane, et al.
Publicado: (2023)

P11-20. HIV-1 gp41-specific mucosal IgAs from highly exposed but IgG seronegative women block HIV-1 epithelial transcytosis and neutralize CD4+ cell infection
por: Tudor, D, et al.
Publicado: (2009)

A Nonparametric Procedure for Defining a New Humoral Immunologic Profile in a Pilot Study on HIV Infected Patients
por: Brombin, Chiara, et al.
Publicado: (2013)

Class B β-arrestin2-dependent CCR5 signalosome retention with natural antibodies to CCR5
por: Venuti, Assunta, et al.
Publicado: (2016)

The Abrogation of Phosphorylation Plays a Relevant Role in the CCR5 Signalosome Formation with Natural Antibodies to CCR5
por: Venuti, Assunta, et al.
Publicado: (2017)

Purification of Gastric Mucosal ECL Cells from a Crude Elutriation Fraction
por: Graham, John
Publicado: (2002)

The Protective HIV-1 Envelope gp41 Antigen P1 Acts as a Mucosal Adjuvant Stimulating the Innate Immunity
por: Xu, Lin, et al.
Publicado: (2021)

Physiology of the ECL cells.
por: Håkanson, R., et al.
Publicado: (1998)

ECL cell morphology.
por: Chen, D., et al.
Publicado: (1998)

Scale down and optimized automated production of [68Ga]68Ga-DOTA-ECL1i PET tracer targeting CCR2 expression
por: Migliari, Silvia, et al.
Publicado: (2023)

Negative regulation of HIV-1 expression by the natural isoform C-terminus truncated STAT5 (STAT5Δ)
por: Crotti, Andrea, et al.
Publicado: (2006)

Native CGRP Neuropeptide and Its Stable Analogue SAX, But Not CGRP Peptide Fragments, Inhibit Mucosal HIV-1 Transmission
por: Mariotton, Jammy, et al.
Publicado: (2021)

Humanized anti CCR4 antibody KW0761 targets HTLV-1 infected CD4+ CCR4+ and CD8+CCR4+ T cells to treat HAM/TSP
por: Yamano, Yoshihisa, et al.
Publicado: (2015)

The biology and physiology of the ECL cell.
por: Håkanson, R., et al.
Publicado: (1994)

Ontogeny of ECL cells in the rat.
por: Sundler, F.
Publicado: (1998)

The biology and pathobiology of the ECL cells.
por: Håkanson, R., et al.
Publicado: (1992)

Hyperplastic proliferations of the ECL cells.
por: Dayal, Y.
Publicado: (1992)

ECL front panel signals
por: von Rüden, Wolfgang
Publicado: (1988)

Summary of the ECL2 workshop
por: Caspers, F, et al.
Publicado: (2007)

ECLS in Pediatric Cardiac Patients
por: Di Nardo, Matteo, et al.
Publicado: (2016)

ECLS: Past, present, and future
por: Bartlett, Robert
Publicado: (2017)

PERINATAL ECLS IN COVID-19
por: CARLISLE, G., et al.
Publicado: (2022)

Human factors in ECLS – A keystone for safety and quality – A narrative review for ECLS providers
por: Swol, Justyna, et al.
Publicado: (2021)

The ecl family gene ecl3(+) is induced by phosphate starvation and contributes to sexual differentiation in fission yeast
por: Ohtsuka, Hokuto, et al.
Publicado: (2023)

Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders
por: Fantuzzi, Laura, et al.
Publicado: (2019)

Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes
por: Leroux-Roels, Geert, et al.
Publicado: (2013)

Relationship of ECL cells and gastric neoplasia.
por: Waldum, H. L., et al.
Publicado: (1998)

Diagnosis and treatment of ECL cell tumors.
por: Cadiot, G., et al.
Publicado: (1998)

Pathogenesis of ECL cell tumors in humans.
por: Bordi, C., et al.
Publicado: (1998)

Physiological significance of ECL-cell histamine.
por: Andersson, K., et al.
Publicado: (1998)

Clinical aspects of ECL-cell abnormalities.
por: Hirschowitz, B. I.
Publicado: (1998)

Severe Corneal Edema Increases ECL From Grafts After DSAEK—Corneal Edema and ECL After DSAEK
por: Gu, Shaofeng, et al.
Publicado: (2022)

CCR5 and CXCR4 antagonist and agonist binding sites
por: Teintze, Martin, et al.
Publicado: (2006)

Natural anti-CCR5 antibodies in HIV-infection and -exposure
por: Lopalco, Lucia
Publicado: (2011)

Clearing the HIV reservoir by transplanting CCR5 deficient stem cells
por: Hütter, Gero
Publicado: (2011)

Recognition and the histopathologic classification of ECL cell proliferations.
por: Dayal, Y.
Publicado: (1998)

Choosing and using ECL (emitter coupled logic)
por: Matthews, Paul L
Publicado: (1983)

Large ECL systems on wire-wrap boards
por: Chopin, M, et al.
Publicado: (1978)

Cannot write session to /tmp/vufind_sessions/sess_a6utgm4kauc032bvm4rl3uj1ps